英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

jerboa

XDict

n. 跳鼠

PyDict

跳鼠

WordNet (r) 3.0 (2006) (WordNet)

jerboa
n 1: mouselike jumping rodent

The Collaborative International Dictionary of English v.0.48 (gcide)

Jerboa \Jer*bo"a\, n. [Ar. yarb[=u]`.] (Zool.)
Any small jumping rodent of the genus {Dipus}, esp. {Dipus
Aegyptius}, which is common in Egypt and the adjacent
countries. The jerboas have very long hind legs and a long
tail. [Written also {gerboa}.]
[1913 Webster]

Note: The name is also applied to other small jumping
rodents, as the {Pedetes Caffer}, of the Cape of Good
Hope.
[1913 Webster]

{Jerboa kangaroo} (Zool.), small Australian kangaroo
({Bettongia penicillata}), about the size of a common
hare.
[1913 Webster]

请选择你想看的字典辞典：

单词	字典	翻译
jerboa	查看　jerboa　在百度字典中的解释	百度英翻中〔查看〕
jerboa	查看　jerboa　在Google字典中的解释	Google英翻中〔查看〕
jerboa	查看　jerboa　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://www.51zidian.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://www.51zidian.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC . . .
LIBTAYO is a prescription medication used to treat adults with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation
LIBTAYO® (cemiplimab-rwlc) for Treatment in Advanced CSCC
LIBTAYO® (cemiplimab-rwlc) is indicated for patients with locally advanced or metastatic cutaneous squamous cell carcinoma (laCSCC or mCSCC) who are not candidates for curative surgery or curative radiation Review Important Safety Information and full Prescribing Information
FDA approves cemiplimab-rwlc for adjuvant treatment of . . .
On October 8, 2025, the Food and Drug Administration approved cemiplimab-rwlc (Libtayo, Regeneron Pharmaceuticals Inc ) for the adjuvant treatment of adults with cutaneous squamous cell carcinoma
Libtayo® (cemiplimab-rwlc) Approved in the U. S. as First and . . .
Libtayo® (cemiplimab-rwlc) Approved in the U S as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
Libtayo: Uses, Side Effects, Warnings - Drugs. com
Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
Libtayo - European Medicines Agency (EMA)
Overview Libtayo is a cancer medicine used in adults to treat: a type of skin cancer called cutaneous squamous cell carcinoma It is used on its own in adults who cannot have surgery or treatment with radiation to cure their disease when the cancer is locally advanced (has spread nearby) or metastatic (has spread to other parts of the body)
FDA Approves Cemiplimab as Adjuvant Immunotherapy for High . . .
Last week, Regeneron announced the U S Food and Drug Administration (FDA) approval of cemiplimab-rwlc (Libtayo) as an adjuvant treatment for adult patients with cutaneous squamous cell carcinoma (CSCC), particularly in those with a high risk of recurrence after surgery and radiation 1 The PD-1 inhibitor was evaluated under priority review
FDA Approves Libtayo for Adjuvant Treatment of High-Risk CSCC
Libtayo® (cemiplimab-rwlc) approved in the US as first and only immunotherapy for adjuvant treatment of cutaneous squamous cell carcinoma (CSCC) with a high risk of recurrence after surgery and
FDA Approves Libtayo for Cutaneous Squamous Cell Carcinoma . . .
The Food and Drug Administration (FDA) has approved Libtayo (cemiplimab-rwlc) for the adjuvant, or postsurgical, treatment of adults with cutaneous squamous cell carcinoma (CSCC) at high risk of recurrence after surgery and radiation, the agency has announced Effectiveness of the drug was determined in the C-POST randomized, double-blind, multicenter, placebo-controlled trial of 415 patients
FDA approves Libtayo as immunotherapy for adjuvant treatment . . .
Regeneron Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the PD-1 inhibitor Libtayo (cemiplimab-rwlc) as an adjuvant treatment for adult patients with cutaneous squamous cell carcinoma (CSCC) at high risk of recurrence after surgery and radiation

中文字典-英文字典 2005-2009